Page last updated: 2024-08-24

fluorodeoxyglucose f18 and lamotrigine

fluorodeoxyglucose f18 has been researched along with lamotrigine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoskinson, M; Kremer, B; Maguire, C; Martin, WR; McEwan, A1
Hong, SB; Joo, EY; Tae, WS1
Doden, T; Hashimoto, T; Oguchi, K; Shimogori, K1

Trials

2 trial(s) available for fluorodeoxyglucose f18 and lamotrigine

ArticleYear
Functional caudate imaging in symptomatic Huntington's disease: positron emission tomography versus single-photon emission computed tomography.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 1995, Volume: 5, Issue:4

    Topics: Anticonvulsants; Case-Control Studies; Caudate Nucleus; Deoxyglucose; Double-Blind Method; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Huntington Disease; Lamotrigine; Male; Middle Aged; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Thalamus; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Triazines

1995
Regional effects of lamotrigine on cerebral glucose metabolism in idiopathic generalized epilepsy.
    Archives of neurology, 2006, Volume: 63, Issue:9

    Topics: Adolescent; Adult; Anticonvulsants; Brain Mapping; Cerebral Cortex; Epilepsy, Generalized; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Lamotrigine; Male; Positron-Emission Tomography; Triazines

2006

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and lamotrigine

ArticleYear
Thalamic and cerebellar hypermetabolism and cortical hypometabolism during absence status epilepticus.
    BMJ case reports, 2017, Jul-28, Volume: 2017

    Topics: Adolescent; Anticonvulsants; Cerebral Cortex; Clonazepam; Delta Rhythm; Electroencephalography; Female; Fluorodeoxyglucose F18; Humans; Lamotrigine; Positron-Emission Tomography; Radiopharmaceuticals; Status Epilepticus; Thalamus; Treatment Outcome; Triazines

2017